Cargando…

Incretins and cardiovascular disease: to the heart of type 2 diabetes?

Major cardiovascular outcome trials and real-life observations have proven that glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), regardless of structural GLP-1 homology, exert clinically relevant cardiovascular protection. GLP-1RAs provide cardioprotective benefits through glycaemic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Solini, Anna, Tricò, Domenico, Del Prato, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473999/
https://www.ncbi.nlm.nih.gov/pubmed/37542009
http://dx.doi.org/10.1007/s00125-023-05973-w

Ejemplares similares